Boone Capital Management LLC
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), Boone Capital Management LLC reported 11 stock positions worth $233.2 million. Its top holding was Medtronic (MDT) at 16.0% of the portfolio, followed by Mirum Pharmaceuticals (MIRM, 14.0%) and Biomarin Pharmaceutical (BMRN, 10.5%). Compared with Q1 2025, it opened 5 new positions, sold out of 6, added to 3 and reduced 3. The biggest buy was a new position in Avantor (AVTR) and the biggest sale Unum (UNM, shares −60%).
- Most Recent 13F
- Q2 2026
- Location
- ATLANTA, GA
- CIK
- 0001882053
- Portfolio Value
- $233.2M (Q2 2025)
- SEC Filing
- 0001214659-25-012210 ↗ filed Aug 14, 2025
Holdings Value
Holdings 11 stocks · $233.2M
| MDT Medtronic PLC | 16.03% | 428,789 | $37.4M | Add +8.9% |
| MIRM Mirum Pharmaceuticals Inc. | 14.00% | 641,448 | $32.6M | Add +6.3% |
| BMRN Biomarin Pharmaceutical Inc. | 10.55% | 447,449 | $24.6M | Add +36.7% |
| AVTR Avantor Inc. | 9.78% | 1,694,482 | $22.8M | New |
| UNM Unum Group | 9.76% | 281,790 | $22.8M | Reduce -59.8% |
| NBIX Neurocrine Biosciences Inc. | 9.72% | 180,338 | $22.7M | New |
| PNTG The Pennant Group Inc. | 8.31% | 649,022 | $19.4M | Reduce -9.8% |
| UNH Unitedhealth Group Inc. | 7.77% | 58,112 | $18.1M | New |
| ICLR Icon PLC | 5.98% | 95,832 | $13.9M | New |
| CI The Cigna Group | 5.05% | 35,600 | $11.8M | Reduce -49.8% |
| ABEO Abeona Therapeutics Inc. | 3.06% | 1,254,658 | $7.1M | New |
Portfolio Sells Q1 2025 → Q2 2025
| UNM Unum Group | Reduce -59.8% | 9.76% | −9.66 |
| GMED Globus Medical Inc. Class A | Sold out | 0.00% | −8.99 |
| MOH Molina Healthcare Inc. | Sold out | 0.00% | −7.57 |
| PRGO Perrigo Co. PLC | Sold out | 0.00% | −6.73 |
| ISRG Intuitive Surgical Inc. | Sold out | 0.00% | −6.56 |
| OFIX Orthofix Medical Inc. | Sold out | 0.00% | −5.26 |
| CI The Cigna Group | Reduce -49.8% | 5.05% | −2.89 |
| BHVN Biohaven Ltd. | Sold out | 0.00% | −2.21 |
| PNTG The Pennant Group Inc. | Reduce -9.8% | 8.31% | +2.15 |
Portfolio Buys Q1 2025 → Q2 2025
| AVTR Avantor Inc. | New | 9.78% | +9.78 |
| NBIX Neurocrine Biosciences Inc. | New | 9.72% | +9.72 |
| UNH Unitedhealth Group Inc. | New | 7.77% | +7.77 |
| ICLR Icon PLC | New | 5.98% | +5.98 |
| MIRM Mirum Pharmaceuticals Inc. | Add +6.3% | 14.00% | +4.75 |
| MDT Medtronic PLC | Add +8.9% | 16.03% | +3.99 |
| ABEO Abeona Therapeutics Inc. | New | 3.06% | +3.06 |
| BMRN Biomarin Pharmaceutical Inc. | Add +36.7% | 10.55% | +2.67 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 16 | $427.5M | TFX, MIRM, CI, IONS, UNH |
| Q1 2026 | 13 | $326.4M | MIRM, IONS, CI, MDT, TFX |
| Q4 2025 | 15 | $318.6M | MDT, MIRM, IONS, CI, BMRN |
| Q3 2025 | 16 | $305.0M | MDT, MIRM, IONS, CI, BBIO |
| Q2 2025 | 11 | $233.2M | MDT, MIRM, BMRN, AVTR, UNM |
| Q1 2025 | 12 | $293.8M | UNM, MDT, MIRM, GMED, CI |
| Q4 2024 | 13 | $296.5M | UNM, GMED, PRGO, MIRM, MOH |
| Q3 2024 | 17 | $385.8M | UNM, GMED, CI, MOH, CHE |
| Q2 2024 | 19 | $383.4M | UNM, GMED, CI, MOH, DHR |
| Q1 2024 | 21 | $494.4M | UNM, CI, MOH, ENOV, BAX |